4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000175
Chief Scientific Officer acquired 13,750 shares (grant or award)
From the SEC's structured data for this filing
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000175
Chief Scientific Officer acquired 13,750 shares (grant or award)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…